omics Innovation to Commercialization serves as Alan K. Hauser's online professional speaking portal.
Dr. Hauser is a biotech business leader and specializes in creating value via new market, strategy and corporate development.
His professional background is highlighted at:
http://www.AlanKHauser.com
Please also see:
http://www.PrecisionCare.me
Additional presentation information is available upon request.
akhauser@me.com
Company Details
- Employees
- 1
- Founded
- -
- Address
- 270 Forest Ave, Palo Alto,california 94301,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.AlanKHauser.com
- Keywords
- Precision Medicine, Companion Diagnostics, CDx-stratified Precision Cancer Care, Pharmacoeconomics, Strategic Planning, ROI-led Pharma Partnering, Collaborative Alliances, Valuations, ROI-led Negotiations, Business Development, Strategy Development, New Market Development, Marketing, Financial Forecasting, Personalized Medicine.
- HQ
- Palo Alto, California
- Competitors
- Temple Wellness (acquired by 记健康）, Medic Affairs Consulting LLC, EAC (Enterprise Analysis Corporation), Manchester Molecular Pathology Innovation Centre, DisruptionMSK, Regulatory Pathfinders, LLC, Center for Precision Medicine, Amwise Diagnostic PTE. LTD., Arizona Precision Medicine, MedPGx.
Omics Innovation To Commercialization Questions
Omics Innovation To Commercialization's website is http://www.AlanKHauser.com
Omics Innovation To Commercialization's LinkedIn profile is https://www.linkedin.com/company/omics-innovation-to-commercialization
Omics Innovation To Commercialization has
1 employees.
View email and phone details for 1
employees at Omics Innovation To Commercialization.
Omics Innovation To Commercialization's industry is
Biotechnology Research
Omics Innovation To Commercialization's top competitors are
Temple Wellness (Acquired By 记健康）,
Medic Affairs Consulting Llc,
Eac (Enterprise Analysis Corporation),
Manchester Molecular Pathology Innovation Centre,
Disruptionmsk,
Regulatory Pathfinders, Llc,
Center For Precision Medicine,
Amwise Diagnostic Pte. Ltd.,
Arizona Precision Medicine,
Medpgx.
Omics Innovation To Commercialization's categories are Biotechnology Research
Omics Innovation To Commercialization's founding year is 2004
